Core Viewpoint - Health 160 (02656.HK) successfully listed on the Hong Kong Stock Exchange, with a significant opening increase of 150.96%, reflecting strong investor interest and a market capitalization exceeding HKD 10 billion [2][4] Company Overview - Health 160 is a leading digital healthcare service provider in China, focusing on a dual business model of "pharmaceutical health product sales" and "digital healthcare solutions" [4][5] - The company has established a vast network connecting over 44,600 healthcare institutions and 902,300 healthcare professionals, serving more than 55.2 million registered users across over 260 cities [6] Financial Performance - The company has shown steady revenue growth over the past three years, with revenues of RMB 525.6 million, RMB 628.6 million, and RMB 620.7 million for 2022, 2023, and 2024 respectively [6] - The adjusted net loss has significantly narrowed from RMB 81.95 million in 2022 to RMB 35.69 million in 2023, and further to RMB 31.47 million in 2024 [6] Market Position and Growth Potential - Health 160 is recognized as the largest digital healthcare service platform in China, with a projected market size of RMB 740.1 billion by 2030, growing at a compound annual growth rate of 22.4% from 2024 to 2030 [7] - The successful listing is expected to enhance the company's market position and accelerate the comprehensive layout of its digital health service ecosystem [7]
健康160上市首日收涨137%，加速布局数字健康服务生态